Diality Inc., a medical device company based in Irvine, Calif., has appointed Ravi Parthasarathy as its new Chief Technology Officer. Parthasarathy brings with him extensive experience in product development team leadership, having most recently worked at ICU Medical as the Vice President of Device Engineering.
Parthasarathy expressed his enthusiasm about joining Diality, citing the company’s mission of improving the lives of those affected by kidney disease as a significant motivation. The Moda-flxTM Hemodialysis System developed by Diality is a patient-centric solution that aims to empower healthcare professionals to make choices that benefit patients and their clinical practice.
Diality is committed to delivering innovative solutions to improve the quality of life for dialysis patients. The Moda-flxTM Hemodialysis System, currently in development, is designed to address the needs of both patients and healthcare providers. Osman Khawar, M.D., the CEO of Diality, expressed his excitement about Parthasarathy joining the team, stating that his expertise and alignment with Diality’s mission, vision, and values make him a perfect fit for the company. Additionally, as Diality continues to grow, Clayton Poppe will transition into the role of Chief Scientific Officer (CSO), overseeing the research, quality, and regulatory functions.
For more information about Diality and its products